# Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection

> **NCT05393505** · PHASE4 · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 344 (estimated)

## Conditions studied

- Neutropenic Fever

## Interventions

- **DRUG:** Meropenem Injection
- **DRUG:** Levofloxacin
- **DRUG:** Amoxicillin Clavulanate
- **DRUG:** Antibiotic

## Key facts

- **NCT ID:** NCT05393505
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-24
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-06-30
- **Target enrollment:** 344 (ESTIMATED)
- **Last updated:** 2022-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393505, "Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05393505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*